Erythropoietin corrects anaemia and reduces the risk of blood transfusion in people with chronic kidney disease, but has uncertain effects on other patient-level outcomes
Year: 2016
Type: article
Source: BMJ Evidence-Based Medicine
Author: David W Johnson
Institutions: The University of Queensland, Princess Alexandra Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2511956280
